Internal Medicine, Endocrinology, Diabetes, & Metabolism · Bowling Green, KY
NPI
1861798431
Since 2011
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
350 Park St
Bowling Green, KY, 42101
Phone (270) 781-5111
Groups this clinician bills Medicare through
Medicare paid, 2024
$407K
22,008 services
Medicare patients, 2024
1,419
Average age 71
Drug cost, 2024
$6.9M
16,450 prescriptions
Company payments, 2025
$3,887
From 37 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronak S Chaudhari was code J0897 (injection, denosumab, 1 mg), 2,880 times for 28 patients. In total Ronak S Chaudhari billed 22,008 services in 116 codes, and Medicare paid $407K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-09-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,880 | 28 | $20.44 | $59K |
| 99214 Office E&M - Established | Office | 1,634 | 701 | $82.20 | $134K |
| 83036 Blood Count | Office | 1,597 | 728 | $9.46 | $15K |
| 80061 Clinical Chemistry | Office | 1,381 | 736 | $13.07 | $18K |
| 84443 Clinical Chemistry | Office | 1,269 | 725 | $16.37 | $21K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 942 | 552 | $12.20 | $11K |
| 80053 Clinical Chemistry | Office | 833 | 470 | $10.28 | $8,563 |
| 80048 Clinical Chemistry | Office | 818 | 462 | $8.26 | $6,756 |
| 83721 Clinical Chemistry | Office | 675 | 465 | $10.21 | $6,889 |
| 82570 Clinical Chemistry | Office | 574 | 474 | $5.04 | $2,895 |
| 82043 Clinical Chemistry | Office | 561 | 463 | $5.62 | $3,152 |
| 95251 Test - Miscellaneous | Office | 558 | 214 | $24.16 | $13K |
| 84439 Clinical Chemistry | Office | 321 | 195 | $8.82 | $2,832 |
| 99232 Hospital E&M - Subsequent | Facility | 170 | 34 | $59.99 | $10K |
| 76536 Ultrasound - Nonspecific | Office | 148 | 147 | $66.15 | $9,791 |
By year: 2022 $390K for 19,940 services; 2023 $385K for 19,294 services; 2024 $407K for 22,008 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 1,597 | 728 | $9.46 | $15K |
| 80061 Clinical Chemistry | 1,381 | 736 | $13.07 | $18K |
| 84443 Clinical Chemistry | 1,269 | 725 | $16.37 | $21K |
| 80053 Clinical Chemistry | 833 | 470 | $10.28 | $8,563 |
| 80048 Clinical Chemistry | 818 | 462 | $8.26 | $6,756 |
| 83721 Clinical Chemistry | 675 | 465 | $10.21 | $6,889 |
| 82570 Clinical Chemistry | 574 | 474 | $5.04 | $2,895 |
| 82043 Clinical Chemistry | 561 | 463 | $5.62 | $3,152 |
| 84439 Clinical Chemistry | 321 | 195 | $8.82 | $2,832 |
| 82306 Clinical Chemistry | 95 | 81 | $29.01 | $2,756 |
Medicare prescription drug claims, 2024
In 2024, the drug Ronak S Chaudhari prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,755 prescriptions and refills. In total Ronak S Chaudhari wrote 16,450 Medicare prescriptions that cost $6.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,755 | 3,943 | 411 | $17K |
| Ozempic Semaglutide | 1,310 | 1,772 | 254 | $1.7M |
| Jardiance Empagliflozin | 1,261 | 2,069 | 278 | $1.2M |
| Atorvastatin Calcium Generic | 779 | 1,917 | 221 | $5,880 |
| Metformin Hcl Generic | 702 | 1,561 | 184 | $3,374 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 633 | 1,126 | 157 | $103K |
| Synthroid Levothyroxine Sodium | 498 | 1,163 | 121 | $32K |
| Rosuvastatin Calcium Generic | 466 | 1,129 | 129 | $4,987 |
| Metformin Hcl Er Metformin Hcl | 435 | 943 | 107 | $3,996 |
| Farxiga Dapagliflozin Propanediol | 426 | 739 | 96 | $401K |
| Trulicity Dulaglutide | 383 | 596 | 78 | $560K |
| Losartan Potassium Generic | 356 | 826 | 100 | $3,291 |
| Tresiba Flextouch U-200 Insulin Degludec | 321 | 575 | 86 | $310K |
| Mounjaro Tirzepatide | 315 | 353 | 55 | $359K |
| Glipizide Generic | 310 | 617 | 70 | $1,982 |
Brand drugs: 8,606 claims; generic drugs: 6,959 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronak S Chaudhari $3,887 ($3,887 in general payments such as food, travel and fees) from 37 companies. The largest payer was Amgen Inc. with $630.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 37 | $630 |
| Novartis Pharmaceuticals Corporation NVS | 19 | $322 |
| Mannkind Corporation MNKD | 20 | $311 |
| Novo Nordisk Inc NVO | 15 | $219 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 13 | $218 |
| Corcept Therapeutics CORT | 13 | $218 |
| Xeris Pharmaceuticals, Inc. | 12 | $202 |
| Tandem Diabetes Care, Inc. TNDM | 10 | $169 |
| Lilly USA, LLC LLY | 10 | $160 |
| Sequel Med Tech, LLC | 7 | $154 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.